Pharmaceutical Technology
SEPTEMBER 16, 2022
Learn how Berlinger came about its innovation process, the five steps of sustainability-driven innovation and collaboration and how it can reduce emissions in its customers’ business cases in the white paper. Download the white paper to learn more. [1] Linda Schwär, VP Marketing, Berlinger & Co. 1] [link]. [2]
Pharmaceutical Technology
FEBRUARY 17, 2023
The data from our recently announced 18-month HOPE-2 open-label extension study showed evidence of disease modification and showed statistically significant differences in the Performance of the Upper Limb (PUL).” “CAP-1002 has shown clinical benefits for cardiac and skeletal muscle myopathy, which few therapies have demonstrated.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
epicur
FEBRUARY 23, 2023
Accurate Ingredient Labeling Accurate labeling also applies more in 503A pharmacies than 503B outsourcing facilities due to stricter regulations on 503B manufacturers. 503A pharmacies have less testing, or sometimes no testing, to verify their label claims. Our blog gives you a comprehensive look at the two. Read the Blog 3.
Quality Matters
FEBRUARY 9, 2023
Of these countries, five have end-to-end manufacturing capacity, and three can import, label, or pack vaccines, a process known as fill and finish. For more information, see the full white paper martin_laura Thu, 02/09/2023 - 13:25 Global Health
Pharmaceutical Technology
NOVEMBER 7, 2022
As a vertically integrated company, SHL Medical prides itself on being an end-to-end partner, offering in-house capabilities at every stage – from design, development and production to final assembly, labelling and packaging. Download the white paper ‘Charleston, USA: A life sciences hub’ here.
pharmaphorum
MARCH 30, 2021
There’s definitely the need to think more creatively and adaptively because the claim you want to put on your label may not be as straightforward to establish as it is for more traditional therapies.”. Read: Adelphi’s Transformational Value: Preparing for a Decade of Radical Change white paper. About the interviewees.
Pharmaceutical Technology
FEBRUARY 21, 2023
Its decision is based on the data obtained from the ongoing, open-label, multinational, single-arm, pivotal Phase III HOPE-B trial. The regulatory approval followed a positive opinion from Committee for Medicinal Products for Human Use (CHMP) in December last year. The trial is designed to evaluate the safety and efficacy of Hemgenix.
Expert insights. Personalized for you.
52 
Let's personalize your content